HOME>Investor Relations>Annual Report>Mitsubishi Tanabe Pharma Corporate Report 2019

Mitsubishi Tanabe Pharma Corporate Report

"Mitsubishi Tanabe Pharma Corporate Report" was selected as one of excellent integrated reports by GPIF's asset managers entrusted with domestic equity investment. For more details, visit the GPIF's website. (February 7, 2020)

Mitsubishi Tanabe Pharma Corporate Report
Corporate Profile

Note) Shigeki Iwane resigned as an Outside Board Director of the Company on October 7, 2019.

Investor Relations

Share Price Information

ReadSpeaker docReader makes documents accessible to all users including users with vision problems letting users view and listen to texts.
User guide